Medtronic tops Q3 revenue and EPS estimates as Cardiovascular and Diabetes drive growth, but margin contraction tempers the ...

The broader market rally, which pushed the benchmark to a two-week record high yesterday, fueled by tech giants like NVIDIA and Tesla, has provided a much-needed breather for investors. This has ...

Medtronic plc MDT is scheduled to report first-quarter fiscal 2026 results on Aug. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.62 exceeded the ...

Medtronic plc MDT recently announced new data for the Evolut Transcatheter Aortic Valve Replacement System (TAVR) at PCR London Valves 2024. This new clinical data gives implanters treating patients ...

In the latest trading session, Medtronic (MDT) closed at $91.97, marking a -1.04% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.02% for the day. At the ...

Medtronic (MDT) stock is in focus as its MiniMed (MMED) business falls on its trading debut after an IPO that raised $560M for the insulin pump maker. Read more here.

Medtronic’s (MDT) diabetes care subsidiary, MiniMed Group, has officially kicked off its IPO roadshow in a bid to list as an ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 results ...

GLASGOW, SCOTLAND - MAY 22: Dr Catherine Calderwood (2L), Chief Medical Officer for Scotland, Professor Sir Pete Downes, Principal and Vice Chancellor (2R), Dr Vanessa Kay, Co-Director DIHS (R) and Dr ...